To determine whether the effect of PEAK1 on in vitro chemosensitivity also is relevant to in vivo tumor growth, we injected female BALB/c mice with 5 × 105 MCF-7DOX or MCF-7 cells and evaluated the response to doxorubicin treatment. The gene discussed is PEAK1; the disease is neoplasm.